GMO has had its long stretch of fourth-quartile Australian equities performance compounded by another investment executive departure.
GMO has had its long stretch of fourth-quartile Australian equities performance compounded by another investment executive departure.
Jeremy Coller, the founder of Coller Capital, gets annoyed by the “misnomer’ that private-equity secondaries are somehow secondhand and, to put it in his inimitable phrase, “crap”. It’s a sensitive point for Coller, who founded his company in 1989 and was one of the world’s first purchasers of existing private-equity interests, later moving on to … Read more